173 related articles for article (PubMed ID: 3301517)
21. Hemodynamic assessment of oral peripheral vasodilator therapy in chronic congestive heart failure: prolonged effectiveness of isosorbide dinitrate.
Williams DO; Bommer WJ; Miller RR; Amsterdam EA; Mason DT
Am J Cardiol; 1977 Jan; 39(1):84-90. PubMed ID: 318795
[TBL] [Abstract][Full Text] [Related]
22. Isosorbide dinitrate in experimental portal hypertension: a study of factors that modulate the hemodynamic response.
Blei AT; Gottstein J
Hepatology; 1986; 6(1):107-11. PubMed ID: 3943776
[TBL] [Abstract][Full Text] [Related]
23. Hemodynamic effects of high-dose sustained-action oral isosorbide dinitrate in stable angina.
Udhoji VN; Heng MK
Am J Med; 1984 Feb; 76(2):234-40. PubMed ID: 6364805
[TBL] [Abstract][Full Text] [Related]
24. Hemodynamic effects of captopril and isosorbide mononitrate started early in acute myocardial infarction: a randomized placebo-controlled study.
Pipilis A; Flather M; Collins R; Coats A; Conway M; Appleby P; Sleight P
J Am Coll Cardiol; 1993 Jul; 22(1):73-9. PubMed ID: 8509566
[TBL] [Abstract][Full Text] [Related]
25. Effect of long-term octreotide and isosorbide dinitrate on haemodynamics in rats with portal vein stenosis.
Lin HC; Huang YT; Cheng YR; Hou MC; Lee FY; Chang FY; Tsai YT; Lee SD
Clin Sci (Lond); 1998 Jun; 94(6):645-50. PubMed ID: 9854463
[TBL] [Abstract][Full Text] [Related]
26. Enhancement of portal pressure reduction by the association of isosorbide-5-mononitrate to propranolol administration in patients with cirrhosis.
Garcia-Pagán JC; Navasa M; Bosch J; Bru C; Pizcueta P; Rodés J
Hepatology; 1990 Feb; 11(2):230-8. PubMed ID: 2307401
[TBL] [Abstract][Full Text] [Related]
27. A comparison between the effects of diltiazem and isosorbide dinitrate on digoxin pharmacodynamics and kinetics in the treatment of patients with chronic ischemic heart failure.
Mahgoub AA; El-Medany AH; Abdulatif AS
Saudi Med J; 2002 Jun; 23(6):725-31. PubMed ID: 12070557
[TBL] [Abstract][Full Text] [Related]
28. Acute administration of carvedilol is more effective than propranolol plus isosorbide-5-mononitrate in the reduction of portal pressure in patients with viral cirrhosis.
Lin HC; Yang YY; Hou MC; Huang YT; Lee FY; Lee SD
Am J Gastroenterol; 2004 Oct; 99(10):1953-8. PubMed ID: 15447755
[TBL] [Abstract][Full Text] [Related]
29. Haemodynamic interactions between the novel calcium sensitiser levosimendan and isosorbide-5-mononitrate in healthy subjects.
Sundberg S; Lehtonen L
Eur J Clin Pharmacol; 2000; 55(11-12):793-9. PubMed ID: 10805056
[TBL] [Abstract][Full Text] [Related]
30. Influence of the vasodilator drug isosorbide dinitrate on ocular circulation.
Hessemer V; Schmidt KG
Arch Ophthalmol; 1997 Mar; 115(3):324-7. PubMed ID: 9076203
[TBL] [Abstract][Full Text] [Related]
31. Propranolol compared with propranolol plus isosorbide-5-mononitrate for portal hypertension in cirrhosis. A randomized controlled study.
García-Pagán JC; Feu F; Bosch J; Rodés J
Ann Intern Med; 1991 May; 114(10):869-73. PubMed ID: 2014947
[TBL] [Abstract][Full Text] [Related]
32. Sustained effect of orally administered isosorbide dinitrate on exercise performance of patients with angina pectoris.
Markis JE; Gorlin R; Mills RM; Williams RA; Schweitzer P; Ransil BJ
Am J Cardiol; 1979 Feb; 43(2):265-71. PubMed ID: 367136
[TBL] [Abstract][Full Text] [Related]
33. Isosorbide dinitrate for the relief of severe heart failure after myocardial infarction.
Mantle JA; Russell RO; Moraski RE; Rackley CE
Am J Cardiol; 1976 Feb; 37(2):263-8. PubMed ID: 1108634
[TBL] [Abstract][Full Text] [Related]
34. Resistance to isosorbide dinitrate in patients with severe chronic heart failure: incidence and attempt at hemodynamic prediction.
Kulick D; Roth A; McIntosh N; Rahimtoola SH; Elkayam U
J Am Coll Cardiol; 1988 Oct; 12(4):1023-8. PubMed ID: 3417975
[TBL] [Abstract][Full Text] [Related]
35. Role of pentobarbitone anaesthesia and sympathetic tone in the haemodynamic effects of isosorbide dinitrate in rats with cirrhosis.
Kirstetter P; Pilette C; Moreau R; Cailmail S; Safka V; Soupison T; Lebrec D
J Gastroenterol Hepatol; 1996 Mar; 11(3):230-5. PubMed ID: 8742918
[TBL] [Abstract][Full Text] [Related]
36. Improved exercise capacity and differing arterial and venous tolerance during chronic isosorbide dinitrate therapy for congestive heart failure.
Leier CV; Huss P; Magorien RD; Unverferth DV
Circulation; 1983 Apr; 67(4):817-22. PubMed ID: 6337742
[TBL] [Abstract][Full Text] [Related]
37. Plasma disposition and hemodynamic effects of a single oral dose of isosorbide dinitrate in human males and females.
Nakatsu K; Brien JF; Savard G; Toffelmire EB; Abdollah H; Bennett BM; Marks GS
Biopharm Drug Dispos; 1992 Jul; 13(5):357-67. PubMed ID: 1498268
[TBL] [Abstract][Full Text] [Related]
38. Comparison of antianginal efficacy of nifedipine and isosorbide dinitrate in chronic stable angina: a long-term, randomized, double-blind, crossover study.
Liang CS; Coplin B; Wellington K
Am J Cardiol; 1985 May; 55(12):9E-14E. PubMed ID: 4003286
[TBL] [Abstract][Full Text] [Related]
39. Comparative hemodynamic effects of placebo and oral isosorbide dinitrate in patients with significant coronary artery disease.
Kasparian H; Wiener L; Duca PR; Gottlieb RS; Brest AN
Am Heart J; 1975 Jul; 90(1):68-74. PubMed ID: 1094819
[TBL] [Abstract][Full Text] [Related]
40. Comparison of the hemodynamic responses to molsidomine and isosorbide dinitrate in congestive heart failure.
Unger P; Vachiery JL; de Cannière D; Staroukine M; Berkenboom G
Am Heart J; 1994 Sep; 128(3):557-63. PubMed ID: 8074020
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
